New Therapies, Risk Factors Drive Hepatitis C Diagnostics

New Therapies, Risk Factors Drive Hepatitis C Diagnostics

This blog post discusses findings from Kalorama Information’s just-published market research report, The World Market for Molecular Diagnostics, 7th Edition (Infectious Disease, Cancer, NAT Blood Screening, Transplantation, Histology/Cytology, Inherited Diseases).

Clinical molecular diagnostics does not lack in targets. Dynamic expansion markets in point-of-care testing and cancer have headlined assay development efforts in recent years, but they are not the only major opportunities in molecular diagnostics.


Top Infectious Diseases in the IVD Market - Hepatitis

Top Infectious Diseases in the IVD Market - Hepatitis

The following analysis is derived from Kalorama Information’s recently released global market research report: The Worldwide Market for Infectious Disease Diagnostic Tests.

This is the third in a series of five posts outlining the leading infectious diseases or infectious disease groups in terms of IVD market sales. Previous posts were for HIV/AIDS and respiratory tract infection tests.

Tests for viral hepatitis infections, primarily hepatitis C virus (HCV) and hepatitis B virus (HBV), are a...